Fig. 3From: Development and validation of an AI-enabled digital breast cancer assay to predict early-stage breast cancer recurrence within 6 yearsAccuracy of training and validation models predicted recurrence risk and performance in patients stratified by high and low risk of recurrence. AUC-ROC curves of A training model and C validation model compared with the optimized clinical model and image feature model. Kaplan–Meier curve of B training and D validation model performance with a cutoff distributing patients as high or low risk for breast cancer recurrenceBack to article page